Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 235Neoplasms 207Carcinoma, Non-Small-Cell Lung 101Colorectal Neoplasms 99Prostatic Neoplasms 93Lung Neoplasms 78Multiple Myeloma 53Melanoma 52Pancreatic Neoplasms 50Head and Neck Neoplasms 50Neoplasm Metastasis 48Leukemia, Myeloid, Acute 44Carcinoma, Hepatocellular 43Ovarian Neoplasms 39Brain Neoplasms 39Squamous Cell Carcinoma of Head and Neck 37Recurrence 37Glioblastoma 33Uterine Cervical Neoplasms 32Glioma 31Sarcoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Stomach Neoplasms 28Lymphoma, Non-Hodgkin 28Lymphoma 27Colonic Neoplasms 27Carcinoma, Renal Cell 26Lymphoma, Follicular 25Esophageal Neoplasms 24Rectal Neoplasms 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mucormycosis × 90 days × Clear all
NCT06900114 2026-03-05

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

Institute of Hematology & Blood Diseases Hospital, China

Completed
60 enrolled
Other hematologic neoplasm

COVID-19, Mucormycosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡